| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/IAI.00673-19 |
| P698 | PubMed publication ID | 31548316 |
| P2093 | author name string | Masahiro Eguchi | |
| Yohsuke Ogawa | |||
| Yoshihiro Shimoji | |||
| Kazumasa Shiraiwa | |||
| Sayaka Nishikawa | |||
| Manae Tsukio | |||
| P2860 | cites work | Vaccines: from empirical development to rational design | Q21089599 |
| Current Status of Veterinary Vaccines | Q27480923 | ||
| Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction | Q29615257 | ||
| Capsular polysaccharide of Erysipelothrix rhusiopathiae, the causative agent of swine erysipelas, and its modification with phosphorylcholine | Q30561249 | ||
| Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough | Q30819553 | ||
| Genomic characterization of ribitol teichoic acid synthesis in Staphylococcus aureus: genes, genomic organization and gene duplication | Q33238903 | ||
| Single nucleotide polymorphism genotyping of Erysipelothrix rhusiopathiae isolates from pigs affected with chronic erysipelas in Japan | Q33593948 | ||
| Serotyping of 800 strains of Erysipelothrix isolated from pigs affected with erysipelas and discrimination of attenuated live vaccine strain by genotyping | Q33713046 | ||
| Construction and vaccine potential of acapsular mutants of Erysipelothrix rhusiopathiae: use of excision of Tn916 to inactivate a target gene. | Q33756359 | ||
| Immunological characterization of a protective antigen of Erysipelothrix rhusiopathiae: identification of the region responsible for protective immunity | Q34000797 | ||
| Truncated surface protective antigen (SpaA) of Erysipelothrix rhusiopathiae serotype 1a elicits protection against challenge with serotypes 1a and 2b in pigs | Q34001645 | ||
| Pathogenicity of Erysipelothrix rhusiopathiae: virulence factors and protective immunity | Q34016444 | ||
| Erysipelothrix rhusiopathiae YS-1 as a live vaccine vehicle for heterologous protein expression and intranasal immunization of pigs | Q34115654 | ||
| Mucosal immunity and vaccines | Q34409172 | ||
| The genome of Erysipelothrix rhusiopathiae, the causative agent of swine erysipelas, reveals new insights into the evolution of firmicutes and the organism's intracellular adaptations | Q35096238 | ||
| Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus | Q35850231 | ||
| Changes in wall teichoic acid during the rod-sphere transition of Bacillus subtilis 168. | Q35980937 | ||
| Mucosal delivery of vaccines in domestic animals | Q36447720 | ||
| Wall teichoic acids of gram-positive bacteria | Q37442758 | ||
| New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. | Q37597487 | ||
| Wall teichoic acid function, biosynthesis, and inhibition | Q37629742 | ||
| Clonal Lineages of Erysipelothrix rhusiopathiae Responsible for Acute Swine Erysipelas in Japan Identified by Using Genome-Wide Single-Nucleotide Polymorphism Analysis | Q38897039 | ||
| Determination of brucella immunoglobulin G agglutinating antibody titer with dithiothreitol | Q40222115 | ||
| Development of an SNP-based PCR assay for rapid differentiation of a Japanese live vaccine strain from field isolates of Erysipelothrix rhusiopathiae | Q41119596 | ||
| Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathway | Q41670400 | ||
| A mariner-based transposition system for Listeria monocytogenes. | Q42845862 | ||
| Use of a live oral vaccine to immunize turkeys against erysipelas | Q43610948 | ||
| Efficacy of oral vaccination against swine erysipelas in growing-finishing pigs in a clinically infected Slovakian pig herd | Q43897693 | ||
| Oral vaccination against mycoplasmal pneumonia of swine using a live Erysipelothrix rhusiopathiae vaccine strain as a vector | Q44635984 | ||
| Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine. | Q51690362 | ||
| Lipoteichoic acid biosynthesis: two steps forwards, one step sideways? | Q61791389 | ||
| Erratum: Corrigendum: Wall teichoic acids mediate increased virulence in Staphylococcus aureus | Q63859650 | ||
| Identification of the Chromosomal Region Essential for Serovar-Specific Antigen and Virulence of Serovar 1 and 2 Strains of Erysipelothrix rhusiopathiae. | Q64945608 | ||
| Antibody Activities of IgM and IgG Fractions from Rabbit Anti-Erysipelothrix rhusiopathiae Sera | Q70417073 | ||
| Attenuated acriflavin-fast Erysipelothrix insidiosa. Relationship between its capability to cause arthritis in mice and immunogenicity in swine | Q70565769 | ||
| Safety of a live attenuated Erysipelothrix rhusiopathiae vaccine for swine | Q79770952 | ||
| P433 | issue | 12 | |
| P921 | main subject | Erysipelothrix rhusiopathiae | Q2346390 |
| swine erysipelas | Q11634308 | ||
| P577 | publication date | 2019-11-18 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Genome-Wide Identification of Virulence Genes in Erysipelothrix rhusiopathiae: Use of a Mutant Deficient in a tagF Homolog as a Safe Oral Vaccine against Swine Erysipelas | |
| P478 | volume | 87 |
| Q94465787 | Erysipelothrix Spp.: Past, Present, and Future Directions in Vaccine Research | cites work | P2860 |
Search more.